CS MEDICA A/S Secures Trademark Approval in Canada

Today, CS MEDICA A/S announces it has secured trademark approval for its brand name CANNASEN® in Canada. A significant milestone for the company’s global footprint and in strengthening its brand recognition globally.

CS MEDICA A/S (“CS MEDICA” or “The Company”), a global MedTech company specializing in CBD and pain management, is proud to take one step closer to the Canadian Market. The company's mission is to improve patient outcomes globally and enhance the quality of care by providing safe and effective products that alleviate symptoms of autoimmune diseases and stress-related disorders.

The trademark approval covers both 03 Cosmetics, 05 Pharmaceuticals and natural remedies, and 10 Medical devices. This achievement is a testament to the company's commitment to quality and its ability to meet the highest standards. It also demonstrates the company’s ability to navigate complex regulatory environments and establish a strong brand presence in key markets.

With the approval of its trademark, CS MEDICA A/S is now positioned to further expand its business operations in Canada. The country has a robust healthcare sector that presents significant growth opportunities for the company.